2-73088060-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001371272.1(RAB11FIP5):c.1558C>A(p.Gln520Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000496 in 1,593,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000059 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000049 ( 0 hom. )
Consequence
RAB11FIP5
NM_001371272.1 missense
NM_001371272.1 missense
Scores
4
15
Clinical Significance
Conservation
PhyloP100: 3.67
Genes affected
RAB11FIP5 (HGNC:24845): (RAB11 family interacting protein 5) Enables gamma-tubulin binding activity. Involved in cellular response to acidic pH; negative regulation of adiponectin secretion; and regulation of protein localization to cell surface. Located in centriolar satellite and mitochondrial outer membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14302534).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RAB11FIP5 | NM_001371272.1 | c.1558C>A | p.Gln520Lys | missense_variant | 3/6 | ENST00000486777.7 | |
RAB11FIP5 | NM_015470.3 | c.1558C>A | p.Gln520Lys | missense_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RAB11FIP5 | ENST00000486777.7 | c.1558C>A | p.Gln520Lys | missense_variant | 3/6 | 5 | NM_001371272.1 | ||
RAB11FIP5 | ENST00000258098.6 | c.1558C>A | p.Gln520Lys | missense_variant | 3/5 | 1 | P1 | ||
RAB11FIP5 | ENST00000479196.1 | n.269C>A | non_coding_transcript_exon_variant | 1/2 | 3 | ||||
RAB11FIP5 | ENST00000493523.2 | n.1467C>A | non_coding_transcript_exon_variant | 2/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152112Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
9
AN:
152112
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000377 AC: 9AN: 238668Hom.: 0 AF XY: 0.0000311 AC XY: 4AN XY: 128788
GnomAD3 exomes
AF:
AC:
9
AN:
238668
Hom.:
AF XY:
AC XY:
4
AN XY:
128788
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000486 AC: 70AN: 1441634Hom.: 0 Cov.: 32 AF XY: 0.0000392 AC XY: 28AN XY: 714706
GnomAD4 exome
AF:
AC:
70
AN:
1441634
Hom.:
Cov.:
32
AF XY:
AC XY:
28
AN XY:
714706
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152112Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74286
GnomAD4 genome
AF:
AC:
9
AN:
152112
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
74286
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2023 | The c.1558C>A (p.Q520K) alteration is located in exon 3 (coding exon 3) of the RAB11FIP5 gene. This alteration results from a C to A substitution at nucleotide position 1558, causing the glutamine (Q) at amino acid position 520 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N
REVEL
Benign
Sift
Benign
.;T
Sift4G
Benign
.;T
Polyphen
0.23
.;B
Vest4
0.34
MutPred
Gain of methylation at Q520 (P = 0.0076);Gain of methylation at Q520 (P = 0.0076);
MVP
0.51
MPC
0.17
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at